{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:45:04Z","timestamp":1790361904837,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204768"],"award-info":[{"award-number":["82204768"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102902"],"award-info":[{"award-number":["82102902"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903141"],"award-info":[{"award-number":["81903141"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-04028-x","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:23:57Z","timestamp":1762255437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Astragaloside IV-loaded zeolitic imidazolate framework-8 based on supercritical fluid as anti-solvent technology to improve bioavailability and anti-tumor activity against non-small cell lung cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Gang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ai","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Fang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"4028_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0140-6736(24)01029-8","volume":"404","author":"ML Meyer","year":"2024","unstructured":"Meyer ML, Fitzgerald BG, Paz-Ares L, Cappuzzo F, J\u00e4nne PA, Peters S, et al. New promises and challenges in the treatment of advanced non-small-cell lung cancer. Lancet. 2024;404:803\u201322.","journal-title":"Lancet"},{"key":"4028_CR2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jamaoncol.2024.0057","volume":"10","author":"M Sorin","year":"2024","unstructured":"Sorin M, Prosty C, Ghaleb L, Nie K, Katergi K, Shahzad MH, et al. Neoadjuvant chemoimmunotherapy for nsclc: a systematic review and meta-analysis. JAMA Oncol. 2024;10:621\u201333.","journal-title":"JAMA Oncol"},{"key":"4028_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S2213-2600(24)00010-9","volume":"12","author":"DP Steinfort","year":"2024","unstructured":"Steinfort DP, Kothari G, Wallace N, Hardcastle N, Rangamuwa K, Dieleman EMT, et al. Systematic endoscopic staging of mediastinum to guide radiotherapy planning in patients with locally advanced non-small-cell lung cancer (SEISMIC): an international, multicentre, single-arm, clinical trial. Lancet Respir Med. 2024;12:467\u201375.","journal-title":"Lancet Respir Med"},{"key":"4028_CR4","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/jcsm.13426","volume":"15","author":"EJ Roeland","year":"2024","unstructured":"Roeland EJ, Fintelmann FJ, Hilton F, Yang R, Whalen E, Tarasenko L, et al. The relationship between weight gain during chemotherapy and outcomes in patients with advanced non-small cell lung cancer. J Cachexia Sarcopenia Muscle. 2024;15:1030\u201340.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4028_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1001\/jamaoncol.2024.1120","volume":"10","author":"TL Chaunzwa","year":"2024","unstructured":"Chaunzwa TL, Qian JM, Li Q, Ricciuti B, Nuernberg L, Johnson JW, et al. Body composition in advanced non-small cell lung cancer treated with immunotherapy. JAMA Oncol. 2024;10:773\u201383.","journal-title":"JAMA Oncol"},{"key":"4028_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01286-3","volume":"8","author":"WZ Zhong","year":"2023","unstructured":"Zhong WZ, Yan HH, Chen KN, Chen C, Gu CD, Wang J, et al. Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial. Signal Transduct Target Ther. 2023;8:76.","journal-title":"Signal Transduct Target Ther"},{"key":"4028_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0140-6736(23)00774-2","volume":"402","author":"SM Lee","year":"2023","unstructured":"Lee SM, Schulz C, Prabhash K, Kowalski D, Szczesna A, Han B, et al. First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study. Lancet. 2023;402:451\u201363.","journal-title":"Lancet"},{"key":"4028_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.annonc.2023.10.004","volume":"35","author":"H Borghaei","year":"2024","unstructured":"Borghaei H, de Marinis F, Dumoulin D, Reynolds C, Theelen WSME, Percent I, et al. Sapphire: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. Ann Oncol. 2024;35:66\u201376.","journal-title":"Ann Oncol"},{"key":"4028_CR9","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jtho.2022.12.017","volume":"18","author":"C Zhou","year":"2023","unstructured":"Zhou C, Chen G, Huang Y, Zhou J, Lin L, Feng J, et al. Camrelizumab plus carboplatin and pemetrexed as first-line treatment for advanced nonsquamous NSCLC: extended follow-up of camel phase 3 trial. J Thorac Oncol. 2023;18:628\u201339.","journal-title":"J Thorac Oncol"},{"key":"4028_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104284","volume":"196","author":"Z Huang","year":"2024","unstructured":"Huang Z, Xiao Z, Yu L, Liu J, Yang Y, Ouyang W. Tumor-associated macrophages in non-small-cell lung cancer: from treatment resistance mechanisms to therapeutic targets. Crit Rev Oncol Hematol. 2024;196:104284.","journal-title":"Crit Rev Oncol Hematol"},{"key":"4028_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ccell.2023.12.013","volume":"42","author":"D Memon","year":"2024","unstructured":"Memon D, Schoenfeld AJ, Ye D, Fromm G, Rizvi H, Zhang X, et al. Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer. Cancer Cell. 2024;42:209\u201324.","journal-title":"Cancer Cell"},{"key":"4028_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-024-00977-z","volume":"19","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Chen Z, Chen L, Dong Q, Yang DH, Zhang Q, et al. Astragali radix (Huangqi): a time-honored nourishing herbal medicine. Chin Med. 2024;19:119.","journal-title":"Chin Med"},{"key":"4028_CR13","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1002\/ptr.6974","volume":"35","author":"B Salehi","year":"2021","unstructured":"Salehi B, Carneiro JNP, Rocha JE, Coutinho HDM, Morais Braga MFB, Sharifi-Rad J, et al. Astragalus species: insights on its chemical composition toward pharmacological applications. Phytother Res. 2021;35:2445\u201376.","journal-title":"Phytother Res"},{"key":"4028_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28166118","volume":"28","author":"Y Liang","year":"2023","unstructured":"Liang Y, Chen B, Liang D, Quan X, Gu R, Meng Z, et al. Pharmacological effects of Astragaloside iv: a review. Molecules. 2023;28:6118.","journal-title":"Molecules"},{"key":"4028_CR15","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2021.4846","volume":"47","author":"T Chen","year":"2021","unstructured":"Chen T, Yang P, Jia Y. Molecular mechanisms of astragaloside\u2013IV in cancer therapy (Review). Int J Mol Med. 2021;47:13. https:\/\/doi.org\/10.3892\/ijmm.2021.4846.","journal-title":"Int J Mol Med"},{"key":"4028_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0878-0","volume":"37","author":"F Xu","year":"2018","unstructured":"Xu F, Cui WQ, Wei Y, Cui J, Qiu J, Hu LL, et al. Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling. J Exp Clin Cancer Res. 2018;37:207.","journal-title":"J Exp Clin Cancer Res"},{"key":"4028_CR17","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1080\/10717544.2022.2086942","volume":"29","author":"Y Xi","year":"2022","unstructured":"Xi Y, Wang W, Ma L, Xu N, Shi C, Xu G, et al. Alendronate modified mPEG-PLGA nano-micelle drug delivery system loaded with Astragaloside has anti-osteoporotic effect in rats. Drug Deliv. 2022;29:2386\u2013402.","journal-title":"Drug Deliv"},{"key":"4028_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123351","volume":"644","author":"X Zhao","year":"2023","unstructured":"Zhao X, Sun L, Wang J, Xu X, Ni S, Liu M, et al. Nose to brain delivery of Astragaloside IV by \u03b2-asarone modified Chitosan nanoparticles for multiple sclerosis therapy. Int J Pharm. 2023;644:123351.","journal-title":"Int J Pharm"},{"key":"4028_CR19","doi-asserted-by":"publisher","first-page":"11573","DOI":"10.1039\/C9RA09040A","volume":"10","author":"G Yue","year":"2020","unstructured":"Yue G, Wang C, Liu B, Wu M, Huang Y, Guo Y, et al. Liposomes co-delivery system of doxorubicin and Astragaloside IV co-modified by folate ligand and octa-arginine polypeptide for anti-breast cancer. RSC Adv. 2020;10:11573\u201381.","journal-title":"RSC Adv"},{"key":"4028_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2023.113560","volume":"231","author":"X Peng","year":"2023","unstructured":"Peng X, Zhang T, Wu Y, Wang X, Liu R, Jin X. mPEG-CS-modified flexible liposomes-reinforced thermosensitive sol-gel reversible hydrogels for ocular delivery of multiple drugs with enhanced synergism. Colloids Surf B Biointerfaces. 2023;231:113560.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4028_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097819","volume":"24","author":"AA Vodyashkin","year":"2023","unstructured":"Vodyashkin AA, Sergorodceva AV, Kezimana P, Stanishevskiy YM. Metal-organic framework (MOF)-a universal material for biomedicine. Int J Mol Sci. 2023;24:7819.","journal-title":"Int J Mol Sci"},{"key":"4028_CR22","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1080\/1061186X.2024.2324935","volume":"32","author":"E Frouhar","year":"2024","unstructured":"Frouhar E, Adibifar A, Salimi M, Karami Z, Shadmani N, Rostamizadeh K. Novel pH-responsive alginate-stabilized curcumin-selenium-ZIF-8 nanocomposites for synergistic breast cancer therapy. J Drug Target. 2024;32:444\u201355.","journal-title":"J Drug Target"},{"key":"4028_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2022.100360","volume":"16","author":"N Li","year":"2022","unstructured":"Li N, Xie L, Wu Y, Wu Y, Liu Y, Gao Y, et al. Dexamethasone-loaded zeolitic imidazolate frameworks nanocomposite hydrogel with antibacterial and anti-inflammatory effects for periodontitis treatment. Mater Today Bio. 2022;16:100360.","journal-title":"Mater Today Bio"},{"key":"4028_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201800950","volume":"7","author":"C Wang","year":"2018","unstructured":"Wang C, Sudlow G, Wang Z, Cao S, Jiang Q, Neiner A, et al. Metal-organic framework encapsulation preserves the bioactivity of protein therapeutics. Adv Healthc Mater. 2018;7:e1800950.","journal-title":"Adv Healthc Mater"},{"key":"4028_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103264","volume":"70","author":"T Bajaj","year":"2022","unstructured":"Bajaj T, Singh C, Gupta GD. Novel metal organic frameworks improves solubility and oral absorption of mebendazole: physicochemical characterization and in vitro-in vivo evaluation. J Drug Deliv Sci Technol. 2022;70:103264.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4028_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtchem.2022.101277","volume":"27","author":"S Anggraini","year":"2023","unstructured":"Anggraini S, Prasetija KA, Yuliana M, Wijaya CJ, Bundjaja V, Angkawijaya AE, et al. pH-responsive hollow core zeolitic-imidazolate framework-8 as an effective drug carrier of 5-fluorouracil. Mater Today Chem. 2023;27:101277.","journal-title":"Mater Today Chem"},{"key":"4028_CR27","doi-asserted-by":"publisher","first-page":"8337","DOI":"10.2147\/IJN.S340764","volume":"16","author":"X Mi","year":"2021","unstructured":"Mi X, Hu M, Dong M, Yang Z, Zhan X, Chang X, et al. Folic acid decorated zeolitic imidazolate framework (ZIF-8) loaded with Baicalin as a nano-drug delivery system for breast cancer therapy. Int J Nanomed. 2021;16:8337\u201352.","journal-title":"Int J Nanomed"},{"key":"4028_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115573","volume":"167","author":"R Zhou","year":"2023","unstructured":"Zhou R, You Y, Zha Z, Chen J, Li Y, Chen X, et al. Biotin decorated celastrol-loaded ZIF-8 nano-drug delivery system targeted epithelial ovarian cancer therapy. Biomed Pharmacother. 2023;167:115573.","journal-title":"Biomed Pharmacother"},{"key":"4028_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123167","volume":"642","author":"S Qin","year":"2023","unstructured":"Qin S, Du X, Wang K, Wang D, Zheng J, Xu H, et al. Vitamin A-modified ZIF-8 lipid nanoparticles for the therapy of liver fibrosis. Int J Pharm. 2023;642:123167.","journal-title":"Int J Pharm"},{"key":"4028_CR30","doi-asserted-by":"publisher","first-page":"9222","DOI":"10.1039\/D0RA10423J","volume":"11","author":"VA Tran","year":"2021","unstructured":"Tran VA, Lee SW. Ph-triggered degradation and release of doxorubicin from zeolitic imidazolate framework-8 (ZIF8) decorated with polyacrylic acid. RSC Adv. 2021;11:9222\u201334.","journal-title":"RSC Adv"},{"key":"4028_CR31","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1021\/acs.jcim.9b00893","volume":"60","author":"YG Proenza","year":"2020","unstructured":"Proenza YG, Longo RL. Simulation of the adsorption and release of large drugs by ZIF-8. J Chem Inf Model. 2020;60:644\u201352.","journal-title":"J Chem Inf Model"},{"key":"4028_CR32","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s11705-020-1927-8","volume":"015","author":"S Feng","year":"2021","unstructured":"Feng S, Zhang X, Shi D, Wang Z. Zeolitic imidazolate framework-8 (ZIF-8) for drug delivery: a critical review. Front Chem Sci Eng. 2021;015:221\u201337.","journal-title":"Front Chem Sci Eng"},{"key":"4028_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering11080788","volume":"11","author":"H Liu","year":"2024","unstructured":"Liu H, Liang X, Peng Y, Liu G, Cheng HW. Supercritical fluids: an innovative strategy for drug development. Bioengineering. 2024;11:788.","journal-title":"Bioengineering"},{"key":"4028_CR34","doi-asserted-by":"crossref","unstructured":"Zhu W, Long J, Shi M. Resveratrol-loaded diacetate fiber by supercritical CO2 fluid assisted impregnation. Materials. 2022;15:5552.","DOI":"10.3390\/ma15165552"},{"key":"4028_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2020.115935","volume":"235","author":"Y He","year":"2020","unstructured":"He Y, Hou X, Guo J, He Z, Guo T, Liu Y, et al. Activation of a gamma-cyclodextrin-based metal-organic framework using supercritical carbon dioxide for high-efficient delivery of Honokiol. Carbohydr Polym. 2020;235:115935.","journal-title":"Carbohydr Polym"},{"key":"4028_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.micromeso.2023.112612","volume":"357","author":"Q Wang","year":"2023","unstructured":"Wang Q, Zhang S, Deng Z, Zhang Y, Jiao Z. Preparation of curcumol-loaded magnetic metal-organic framework using supercritical solution impregnation process. Microporous Mesoporous Mater. 2023;357:112612.","journal-title":"Microporous Mesoporous Mater"},{"key":"4028_CR37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jcou.2018.12.022","volume":"30","author":"R Monteagudo-Olivan","year":"2019","unstructured":"Monteagudo-Olivan R, Cocero MJ, Coronas J, Rodr\u00edguez-Rojo S. Supercritical CO2 encapsulation of bioactive molecules in carboxylate based MOFs. J CO2 Util. 2019;30:38\u201347.","journal-title":"J CO2 Util"},{"key":"4028_CR38","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1007\/s13346-022-01283-7","volume":"13","author":"R Kumar","year":"2023","unstructured":"Kumar R, Thakur AK, Kali G, Pitchaiah KC, Arya RK, Kulabhi A. Particle preparation of pharmaceutical compounds using supercritical antisolvent process: current status and future perspectives. Drug Deliv Transl Res. 2023;13:946\u201365.","journal-title":"Drug Deliv Transl Res"},{"key":"4028_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2024.139591","volume":"452","author":"S Gholivand","year":"2024","unstructured":"Gholivand S, Tan TB, Yusoff MM, Choy HW, Teow SJ, Wang Y, et al. Advanced fabrication of complex biopolymer microcapsules via RSM-optimized supercritical carbon dioxide solution-enhanced dispersion: a comparative analysis of various microencapsulation techniques. Food Chem. 2024;452:139591.","journal-title":"Food Chem"},{"key":"4028_CR40","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1021\/je5011328","volume":"60","author":"J Jia","year":"2015","unstructured":"Jia J, Zabihi F, Gao Y, Zhao Y. Solubility of glycyrrhizin in supercritical carbon dioxide with and without cosolvent. J Chem Eng Data. 2015;60:1744\u20139.","journal-title":"J Chem Eng Data"},{"key":"4028_CR41","first-page":"456","volume":"12","author":"G Yang","year":"2017","unstructured":"Yang G, Li Z, Shao Q, Feng N. Measurement and correlation study of Silymarin solubility in supercritical carbon dioxide with and without a cosolvent using semi-empirical models and back-propagation artificial neural networks. Asian J Pharm Sci. 2017;12:456\u201363.","journal-title":"Asian J Pharm Sci"},{"key":"4028_CR42","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1039\/D2BM00149G","volume":"10","author":"J Liu","year":"2022","unstructured":"Liu J, Liu S, Wu Y, Xu X, Li Q, Yang M, et al. Curcumin doped zeolitic imidazolate framework nanoplatforms as multifunctional nanocarriers for tumor chemo\/immunotherapy. Biomater Sci. 2022;10:2384\u201393.","journal-title":"Biomater Sci"},{"key":"4028_CR43","doi-asserted-by":"publisher","first-page":"6377","DOI":"10.2147\/IJN.S387715","volume":"17","author":"H Wu","year":"2022","unstructured":"Wu H, Liu Y, Chen L, Wang S, Liu C, Zhao H, Jin M, Chang S, Quan X, Cui M, Wan H, Gao Z, Huang W. Combined biomimetic MOF-RVG15 nanoformulation efficient over BBB for effective anti-glioblastoma in mice model. Int J Nanomed. 2022;17:6377\u201398.","journal-title":"Int J Nanomed"},{"key":"4028_CR44","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1007\/s13346-021-00978-7","volume":"12","author":"Z Li","year":"2022","unstructured":"Li Z, Yang G, Wang R, Wang Y, Wang J, Yang M, et al. \u03b3-cyclodextrin metal-organic framework as a carrier to deliver triptolide for the treatment of hepatocellular carcinoma. Drug Deliv Transl Res. 2022;12:1096\u2013104.","journal-title":"Drug Deliv Transl Res"},{"issue":"4","key":"4028_CR45","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1093\/jaoacint\/qsab041","volume":"104","author":"R Sun","year":"2021","unstructured":"Sun R, Hu C, Dou Q, Luan L. Simultaneous determination of nine residual solvents in Sorafenib Tosylate by gas chromatography. J AOAC Int. 2021;104(4):1005\u20139.","journal-title":"J AOAC Int"},{"key":"4028_CR46","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1080\/13880209.2022.2125539","volume":"60","author":"S Sun","year":"2022","unstructured":"Sun S, Liu L, Song H, Li H. Pharmacokinetic study on the co-administration of abemaciclib and Astragaloside IV in rats. Pharm Biol. 2022;60:1944\u20138.","journal-title":"Pharm Biol"},{"key":"4028_CR47","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1021\/je300987d","volume":"58","author":"J Jin","year":"2013","unstructured":"Jin J, Ning YY, Hu K, Wu H, Zhang Z. Solubility of p-nitroaniline in supercritical carbon dioxide with and without mixed cosolvents. J Chem Eng Data. 2013;58:1464\u20139.","journal-title":"J Chem Eng Data"},{"key":"4028_CR48","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1007\/s10876-022-02349-9","volume":"34","author":"M Mazloum-Ardakani","year":"2023","unstructured":"Mazloum-Ardakani M, Shaker-Ardakani N, Ebadi A. Development of metal-organic frameworks (ZIF-8) as low-cost carriers for sustained release of hydrophobic and hydrophilic drugs: in vitro evaluation of anti-breast cancer and anti-infection effect. J Clust Sci. 2023;34:1861\u201376.","journal-title":"J Clust Sci"},{"key":"4028_CR49","doi-asserted-by":"publisher","first-page":"6491","DOI":"10.1007\/s11696-023-02953-7","volume":"77","author":"Y Wang","year":"2023","unstructured":"Wang Y, Han X, Qin XY, Zhang Y, Guo N, Zhu HL, et al. A solid preparation of phytochemicals: improvement of the solubility and bioavailability of Astragaloside IV based on \u03b2-cyclodextrin microencapsulation. Chem Pap. 2023;77:6491\u2013503.","journal-title":"Chem Pap"},{"key":"4028_CR50","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1080\/17425247.2020.1783236","volume":"17","author":"R Sun","year":"2020","unstructured":"Sun R, Zhang A, Ge Y, Gou J, Yin T, He H, et al. Ultra-small-size Astragaloside-IV loaded lipid nanocapsules eye drops for the effective management of dry age-related macular degeneration. Expert Opin Drug Deliv. 2020;17:1305\u201320.","journal-title":"Expert Opin Drug Deliv"},{"key":"4028_CR51","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-023-02650-4","volume":"24","author":"Z Liu","year":"2023","unstructured":"Liu Z, Lv Y, Zheng G, Wu W, Che X. Chitosan\/polylactic acid nanofibers containing Astragaloside IV as a new biodegradable wound dressing for wound healing. AAPS PharmSciTech. 2023;24:202.","journal-title":"AAPS PharmSciTech"},{"key":"4028_CR52","doi-asserted-by":"publisher","first-page":"10186","DOI":"10.1073\/pnas.0602439103","volume":"103","author":"KS Park","year":"2006","unstructured":"Park KS, Ni Z, C\u00f4t\u00e9 AP, Choi JY, Huang R, Uribe-Romo FJ, et al. Exceptional chemical and thermal stability of zeolitic imidazolate frameworks. Proc Natl Acad Sci U S A. 2006;103:10186\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4028_CR53","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.micromeso.2018.12.035","volume":"279","author":"HX Zhang","year":"2019","unstructured":"Zhang HX, Zhao M, Lin YS. Stability of ZIF-8 in water under ambient conditions. Microporous Mesoporous Mater. 2019;279:201\u201310.","journal-title":"Microporous Mesoporous Mater"},{"key":"4028_CR54","doi-asserted-by":"publisher","first-page":"8900","DOI":"10.1021\/ja202154j","volume":"133","author":"D Fairen-Jimenez","year":"2011","unstructured":"Fairen-Jimenez D, Moggach SA, Wharmby MT, Wright PA, Parsons S, D\u00fcren T. Opening the gate: framework flexibility in ZIF-8 explored by experiments and simulations. J Am Chem Soc. 2011;133:8900\u20132.","journal-title":"J Am Chem Soc"},{"key":"4028_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.983663","volume":"10","author":"A Rafizadeh","year":"2022","unstructured":"Rafizadeh A, Bhalla A, Sharma N, Kumar K, Zamani N, McDonald R, et al. Evaluating new simplified assays for harm reduction from methanol poisoning using chromotropic acid kits: an analytical study on Indian and Iranian alcoholic beverages. Front Public Health. 2022;10:983663.","journal-title":"Front Public Health"},{"issue":"9","key":"4028_CR56","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1007\/s11095-024-03744-9","volume":"41","author":"F Kias","year":"2024","unstructured":"Kias F, Bodmeier R. Acceleration of final residual solvent extraction from poly(lactide-co-glycolide) microparticles. Pharm Res. 2024;41(9):1869\u201379.","journal-title":"Pharm Res"},{"key":"4028_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12050425","volume":"12","author":"H Shim","year":"2020","unstructured":"Shim H, Sah H. Qualification of non-halogenated organic solvents applied to microsphere manufacturing process. Pharmaceutics. 2020;12:425.","journal-title":"Pharmaceutics"},{"key":"4028_CR58","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.2147\/DDDT.S447496","volume":"18","author":"Y Liu","year":"2024","unstructured":"Liu Y, Liang Y, Yuhong J, Xin P, Han JL, Du Y, Yu X, Zhu R, Zhang M, Chen W, Ma Y. Advances in nanotechnology for enhancing the solubility and bioavailability of poorly soluble drugs. Drug Des Devel Ther. 2024;18:1469\u201395.","journal-title":"Drug Des Devel Ther"},{"key":"4028_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.dyepig.2019.108094","volume":"174","author":"J Peng","year":"2020","unstructured":"Peng J, Liu Y, Wang M, Huang S, Liu M, Zhou Y, et al. Synthesis, crystal structures, and mechanochromic properties of bulky trialkylsilylacetylene-substituted aggregation-induced-emission-active 1,4-dihydropyridine derivatives. Dyes Pigments. 2020;174:108094.","journal-title":"Dyes Pigments"},{"key":"4028_CR60","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.apsb.2018.09.003","volume":"9","author":"Y He","year":"2019","unstructured":"He Y, Zhang W, Guo T, Zhang G, Qin W, Zhang L, et al. Drug nanoclusters formed in confined nano-cages of CD-MOF: dramatic enhancement of solubility and bioavailability of Azilsartan. Acta Pharm Sin B. 2019;9:97\u2013106.","journal-title":"Acta Pharm Sin B"},{"key":"4028_CR61","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ijpharm.2018.11.074","volume":"556","author":"J Xu","year":"2019","unstructured":"Xu J, Wu L, Guo T, Zhang G, Wang C, Li H, et al. A ship-in-a-bottle strategy to create folic acid nanoclusters inside the nanocages of \u03b3-cyclodextrin metal-organic frameworks. Int J Pharm. 2019;556:89\u201396.","journal-title":"Int J Pharm"},{"key":"4028_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2019.111845","volume":"296","author":"KA Kurnia","year":"2019","unstructured":"Kurnia KA, Harimurti S, Yung HK, Baraheng A, Alimin MA, Dagang M, et al. Understanding the effect of pH on the solubility of Gamavuton-0 in the aqueous solution: experimental and COSMO-RS modelling. J Mol Liq. 2019;296:111845.","journal-title":"J Mol Liq"},{"key":"4028_CR63","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ijpharm.2019.05.061","volume":"566","author":"A Hussain","year":"2019","unstructured":"Hussain A, Shakeel F, Singh SK, Alsarra IA, Faruk A, Alanazi FK, et al. Solidified SNEDDS for the oral delivery of rifampicin: evaluation, proof of concept, in vivo kinetics, and in silico GastroPlus\u2122 simulation. Int J Pharm. 2019;566:203\u201317.","journal-title":"Int J Pharm"},{"key":"4028_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2020.128405","volume":"343","author":"N Diaz-Morales","year":"2021","unstructured":"Diaz-Morales N, Cavia-Saiz M, Salazar G, Rivero-P\u00e9rez MD, Mu\u00f1iz P. Cytotoxicity study of bakery product melanoidins on intestinal and endothelial cell lines. Food Chem. 2021;343:128405.","journal-title":"Food Chem"},{"key":"4028_CR65","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1111\/1750-3841.15839","volume":"86","author":"Y Cai","year":"2021","unstructured":"Cai Y, Guan J, Wang W, Wang L, Su J, Fang L. pH and light-responsive polycaprolactone\/curcumin@zif-8 composite films with enhanced antibacterial activity. J Food Sci. 2021;86:3550\u201362.","journal-title":"J Food Sci"},{"key":"4028_CR66","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1021\/acsbiomaterials.3c00090","volume":"9","author":"Z Xu","year":"2023","unstructured":"Xu Z, Zhang Y, Lu D, Zhang G, Li Y, Lu Z, et al. Antisenescence ZIF-8\/resveratrol nanoformulation with potential for enhancement of bone fracture healing in the elderly. ACS Biomater Sci Eng. 2023;9:2636\u201346.","journal-title":"ACS Biomater Sci Eng"},{"key":"4028_CR67","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/zaac.202000285","volume":"24","author":"W Lin","year":"2020","unstructured":"Lin W, Gong J, Ye W, Huang X, Chen J. Polyhydroxy fullerene-loaded ZIF\u20108 nanocomposites for better photodynamic therapy. Z Anorg Allg Chem. 2020;24:1900\u20133.","journal-title":"Z Anorg Allg Chem"},{"key":"4028_CR68","volume":"8","author":"K Wang","year":"2023","unstructured":"Wang K, Cai M, Yin D, Zhu R, Fu T, Liao S, et al. Functional metal\u2013organic framework nanoparticles loaded with polyphyllin I for targeted tumor therapy. Journal of Science: Advanced Materials and Devices. 2023;8:100548.","journal-title":"Journal of Science: Advanced Materials and Devices"},{"key":"4028_CR69","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1039\/D2TB02328H","volume":"11","author":"F Xu","year":"2023","unstructured":"Xu F, Li M, Que Z, Su M, Yao W, Zhang Y, et al. Combined chemo-immuno-photothermal therapy based on ursolic acid\/astragaloside IV-loaded hyaluronic acid-modified polydopamine nanomedicine inhibiting the growth and metastasis of non-small cell lung cancer. J Mater Chem B. 2023;11:3453\u201372.","journal-title":"J Mater Chem B"},{"key":"4028_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.legalmed.2023.102298","volume":"64","author":"A Nakamura","year":"2023","unstructured":"Nakamura A, Ninomiya K, Fukasawa M, Ikematsu N, Kawakami Y. Accidental carbon dioxide poisoning due to dry ice during a funeral wake: an autopsy case. Leg Med (Tokyo). 2023;64:102298.","journal-title":"Leg Med (Tokyo)"},{"key":"4028_CR71","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.supflu.2017.12.038","volume":"134","author":"E Badens","year":"2018","unstructured":"Badens E, Masmoudi Y, Mouahid A, Crampon C. Current situation and perspectives in drug formulation by using supercritical fluid technology. J Supercrit Fluids. 2018;134:274\u201383.","journal-title":"J Supercrit Fluids"},{"issue":"8","key":"4028_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering11080788","volume":"11","author":"H Liu","year":"2024","unstructured":"Liu H, Liang X, Peng Y, Liu G, Cheng H. Supercritical fluids: an innovative strategy for drug development. Bioengineering. 2024;11(8):788.","journal-title":"Bioengineering"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04028-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-04028-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04028-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T22:28:29Z","timestamp":1762295309000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-04028-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4028"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-04028-x","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted by adhering to the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 8023, revised 1978). All experimental protocols were confirmed by the Institutional Review and Ethics Board of Ninth People\u2019s Hospital, affiliated with Shanghai Jiao Tong University School of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the listed authors have participated in the study, and have approved the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"386"}}